Health Care: Drugs

Cerus Corp (CERS: NASDAQ)

$5.2 n/a | n/a%
07/27/15 - 03:59 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 36.42M 39.66M 36.79M 33.04M
Cost of Sales 19.98M 22.25M 20.07M 17.82M
Gross Operating Profit 16.44M 17.41M 16.71M 15.23M
Selling, General, and Administrative Expenses 37.73M 29.96M 25.66M 23.05M
Research & Development 21.80M 15.19M 7.60M 7.18M
Operating Income before D & A (EBITDA) -43.09M -27.74M -16.56M -15.00M
Depreciation & Amortization 1.42M 557.00K 744.00K 922.00K
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net 6.54M -14.30M 2.18M -94.00K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -37.96M -42.60M -15.12M -16.02M
Interest Expense 599.00K 520.00K 551.00K 964.00K
Pre-Tax Income -38.56M -43.12M -15.68M -16.98M
Income Taxes 195.00K 218.00K 242.00K 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -38.76M -43.34M -15.92M -16.98M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -38.76M -43.34M -15.92M -16.98M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -38.76M -43.34M -15.92M -16.98M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-38.76M -43.34M -15.92M -16.98M
Preferred Dividends
Net Income Available To Common -38.76M -43.34M -15.92M -16.98M
Basic EPS from Continuing Ops. -0.52 -0.64 -0.29 -0.35
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.52 -0.64 -0.29 -0.35
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.52 -0.64 -0.29 -0.35
Basic Normalized Net Income/Share -0.52 -0.64 -0.29 -0.35
EPS fr Continuing Ops. -0.52 -0.64 -0.29 -0.35
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.52 -0.64 -0.29 -0.35
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) -0.09 0.00 -0.04 0.00
EPS, Total -0.61 -0.64 -0.33 -0.35
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.52 -0.64 -0.29 -0.35
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with CERS

Latest CERS Headlines from TheStreet

More Financial News for CERS

Press Releases for CERS

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter